Articles Posted in Defective Medicine

Blood Thinner Pradaxa Raises Safety Concerns
Borchardt Law Firm Team

Pradaxa is a new blood thinning drug touted as an alternative to the traditional (and problematic) warfarin, a drug in use since the 1950’s. It is an oral treatment that has been approved in preventing strokes in patients who suffer from atrial fibrillation, an irregular heartbeat. Pradaxa’s main goal is to avoid the complications associated…

Continue reading ›
Diabetes Drug Actos May Be Linked to Bladder Cancer
Borchardt Law Firm Team

Actos, an oral diabetes drug produced by Takeda Pharmaceuticals, may increase the risk of developing bladder cancer. Several studies have noted a connection between high and long-term doses of Actos and prevalence of bladder cancer. There have recently been many lawsuits filed seeking redress for physical and mental distress caused by this drug’s reported tendency…

Continue reading ›
Senate Passes Bill on Inspection of Foreign Drug Manufacturers
Borchardt Law Firm Team

The Senate has recently passed a bill that would require greater oversight of drug manufacturing facilities overseas. This bill is concerned with increasing the safety and quality of imported medicine. The FDA is responsible for inspecting all U.S. drug manufacturers, but it has failed to account for the complexities of today’s industrial environment. According to…

Continue reading ›
Blood Thinning Drug Coumadin Shows to Be Fatal with Out Proper Monitoring
Borchardt Law Firm Team

An anticoagulant drug proves to be fatal with out proper monitoring of the medication. Coumadin, also known as Warfarin, is a blood thinning prescription used in patients to prevent blood clots, heart attack and stroke. Coumadin is mostly prescribed to patients with an artificial heart valve, atrial fibrillation (an irregular heart beat), deep venous thrombosis…

Continue reading ›
FDA Vote Leads Bayer to Update Yaz Labeling
Borchardt Law Firm Team

The FDA (Food and Drug Administration) continues to express concern about the potential side effects of Yaz birth control. Over the past few years health experts and the FDA have shown an increased apprehension over the once-a-day pill. Yaz, unlike older contraceptive pills, contains drospirenone, an ingredient that may be a leading factor in an…

Continue reading ›
Yaz Lawsuits Increase as Birth Controls Containing Drospirenone Create Concern
Borchardt Law Firm Team

A falsely advertised Yaz commercial sparks possible health concerns for the birth control pill. Yaz, a product of Bayer Healthcare Pharmaceuticals, has received thousands of complaints from women across the U.S. about unsatisfying results after taking the pill for several months. In 2007 Yaz launched an advertisement that promoted the pill to treat severe premenstrual…

Continue reading ›
What Caused Your Child’s Cerebral Palsy?
Borchardt Law Firm Team

About one out of every 400 Americans born is diagnosed with Cerebral palsy. If your child suffers from Cerebral palsy that developed during the early stages of life or during childbirth contact our law firm Borchardt Law Firm to discuss your legal options. Cerebral palsy is a complex affliction that involves damage to the part…

Continue reading ›
Actos Lawsuits Increase as FDA Warns Diabetes Patients About Bladder Cancer Risk
Borchardt Law Firm Team

In June of 2011, just two days after Actos was pulled off the shelves in France and Germany, the FDA warned doctors and patients in the U.S. about the increased risk of bladder cancer while taking the medicine for over a year. Takeda, the largest pharmaceutical company based in Japan, is now facing hundreds of…

Continue reading ›

Contact Us

  1. 1 Free Initial Consultation
  2. 2 Over 30 Years of Experience
  3. 3 High Quality Representation

Complete the contact form or call us at 800-994-2115 to schedule your free initial consultation.

Fill out the form and we'll respond within 1 Hour during business hours

800-994-2115